ECSP982728A - FENIL RENT IMIDAZOLES - Google Patents
FENIL RENT IMIDAZOLESInfo
- Publication number
- ECSP982728A ECSP982728A ECSP982728A ECSP982728A EC SP982728 A ECSP982728 A EC SP982728A EC SP982728 A ECSP982728 A EC SP982728A EC SP982728 A ECSP982728 A EC SP982728A
- Authority
- EC
- Ecuador
- Prior art keywords
- formula
- hypo
- nervous system
- central nervous
- gastrointestinal tract
- Prior art date
Links
- 150000002460 imidazoles Chemical class 0.000 title 1
- 210000003169 central nervous system Anatomy 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 3
- 208000026935 allergic disease Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 206010011953 Decreased activity Diseases 0.000 abstract 1
- 208000010412 Glaucoma Diseases 0.000 abstract 1
- 229940124056 Histamine H1 receptor antagonist Drugs 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 239000000938 histamine H1 antagonist Substances 0.000 abstract 1
- 208000013403 hyperactivity Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 230000037361 pathway Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 208000019116 sleep disease Diseases 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se describe fenil-alquil-imidazoles nuevos de la fórmula (gráfico), donde R1 y R7, m, n, p, q, X, Y, Z,R y R15 son como definimos en la especificación. También se describen composiciones farmcéuticas que comprenden a los compuestos de la fórmula I. Además se describen los métodos para tratar la alérgia inflamación, enfermedad cardiovascular, hipertensión, glaucoma, trastornos del sueño, enfermedades del tracto gastrointestinal, estados de hiper e hipo-movilidad del tracto gastrointestinal, trastornos del sistema nervioso central, hipo-movilidad del tyracto gastrointestinal, trastornos del sistema nervioso central, hipo e hiper-actividad del sistema nervioso central, enfermedad de Alzheimer, esquizofrenia, obesidad y migraña administrando los compuestos de la fórmula I. Además se describen los métodos para el tratamiento de las respuestas alérgicas de las vias superiores que comprenden administrar un compuesto, o su sal o solvato, de la fórmula I en combinación o mezcla con un antagonista del receptor H1 de histamina.Novel phenyl-alkyl-imidazoles of the formula (graph) are described, where R1 and R7, m, n, p, q, X, Y, Z, R and R15 are as defined in the specification. Pharmaceutical compositions comprising the compounds of formula I are also described. In addition, methods for treating allergy, inflammation, cardiovascular disease, hypertension, glaucoma, sleep disorders, diseases of the gastrointestinal tract, hyper and hypo-mobility states of the gastrointestinal tract, disorders of the central nervous system, hypo-mobility of the gastrointestinal tract, disorders of the central nervous system, hypo and hyper-activity of the central nervous system, Alzheimer's disease, schizophrenia, obesity and migraine by administering the compounds of formula I. In addition Methods for the treatment of allergic responses of the upper pathways are described which comprise administering a compound, or its salt or solvate, of formula I in combination or mixture with a histamine H1 receptor antagonist.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982728 ECSP982728A (en) | 1998-11-05 | 1998-11-05 | FENIL RENT IMIDAZOLES |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982728 ECSP982728A (en) | 1998-11-05 | 1998-11-05 | FENIL RENT IMIDAZOLES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP982728A true ECSP982728A (en) | 1999-05-06 |
Family
ID=42043646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP982728 ECSP982728A (en) | 1998-11-05 | 1998-11-05 | FENIL RENT IMIDAZOLES |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP982728A (en) |
-
1998
- 1998-11-05 EC ECSP982728 patent/ECSP982728A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5641054B2 (en) | Novel compound, kinesin spindle protein inhibitor and application thereof | |
| WO2007038209A3 (en) | Fused tetracyclic mglur1 antagonists as therapeutic agents | |
| BRPI0407305A (en) | Cannabinoid receptor ligands and their uses | |
| EA200500342A1 (en) | HETEROCYCLIC SUBSTITUTED PIPERASINES FOR THE TREATMENT OF SCHIZOPHRENIA | |
| TW201242961A (en) | FAAH inhibitors | |
| UY28011A1 (en) | TIAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | |
| PA8493701A1 (en) | COMPOUNDS TO TREAT OBESITY | |
| BR0211740A (en) | Spiro compounds | |
| WO2018188641A1 (en) | Pharmaceutical composition containing mor agonist and kor agonist, and uses thereof | |
| DE60025604D1 (en) | Benzimidazole derivatives and pharmaceutical compositions containing them | |
| DE60231341D1 (en) | FLUOROUS AND SULFONYLAMINE-BASED, 3,6-DISUBSTITUIERPTORANTAGONISTS | |
| TW200609231A (en) | Mglur1 antagonists as therapeutic agents | |
| SI1716152T1 (en) | Condensed heterocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders | |
| EA200500173A1 (en) | 3,6-DISPOSABLE AZABICYCLO [3.1.0] HEXANE DERIVATIVES AS ANTAGONISTS OF MUSCARIN RECEPTORS | |
| EA200600071A1 (en) | Derivatives of N-phenylpyrazine and Methods for the Prevention or Treatment of Diseases Associated with 5HT-Receptor | |
| ATE496922T1 (en) | MGLUR1 ANTAGONISTS AS THERAPEUTIC AGENTS | |
| CN106478502A (en) | 1,2,3,4- tetrahydro isoquinoline derivative, its preparation method and application | |
| AR041942A1 (en) | DERIVATIVES OF 10-OXA -1-AZA-DIBENZO [A, D] CICLOHEPTENO-7-CARBOXILICO AS CCR1 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DEMELINIZING DISEASE | |
| Davood et al. | Design, synthesis and protection against pentylenetetrazole-induced seizure of N-aryl derivatives of the phthalimide pharmacophore | |
| EA200501593A1 (en) | AZABICYCLIC DERIVATIVES AS ANTAGONISTS OF MUSCARINE RECEPTOR | |
| PE130799A1 (en) | FENIL-ALQUIL-IMIDAZOLES | |
| CO5011065A1 (en) | LIGANDOS DEL RECEPTOR H3, OF THE FENIL-RENT-IMIDAZOL TYPE | |
| CA3181979A1 (en) | Targeted aberrant alpha-synuclein species and induced ubiquitination and proteosomal clearance via co-recruitment of an e3-ligase system | |
| MX2008002366A (en) | FUSED TRICYCLIC mGluR1 ANTAGONISTS AS THERAPEUTIC AGENTS. | |
| AU2024263053A1 (en) | Imidazole containing compounds, derivatives thereof, and uses thereof |